Assignee
SUGEN INC
US158 patents
Top patents by PatentIndex Score
US6133305AOct 17, 2000
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
SUGEN INC125 citations99
US5942385AAug 24, 1999
Method for molecular diagnosis of tumor angiogenesis and metastasis
SUGEN INC145 citations99
US5886020AMar 23, 1999
3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC376 citations99
US5883116AMar 16, 1999
3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC180 citations99
US5883113AMar 16, 1999
3-(4'-Bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
SUGEN INC373 citations99
US5880141AMar 9, 1999
Benzylidene-Z-indoline compounds for the treatment of disease
SUGEN INC106 citations99
US5834504ANov 10, 1998
3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease
SUGEN INC358 citations99
US5804396ASep 8, 1998
Assay for agents active in proliferative disorders
SUGEN INC480 citations99
US5792783AAug 11, 1998
3-heteroaryl-2-indolinone compounds for the treatment of disease
SUGEN INC589 citations99
US5650415AJul 22, 1997
Quinoline compounds
SUGEN INC235 citations99
US7186716B2Mar 6, 2007
3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
SUGEN INC64 citations98
US6573293B2Jun 3, 2003
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC174 citations98
US6506763B2Jan 14, 2003
3-(substituted)-2-indolinones compounds and use thereof as inhibitors of protein kinase activity
SUGEN INC76 citations98
US6395734B1May 28, 2002
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC79 citations98
US5792771AAug 11, 1998
Quinazoline compounds and compositions thereof for the treatment of disease
SUGEN INC155 citations98
US5789427AAug 4, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC264 citations98
US5773476AJun 30, 1998
Methods and compositions for inhibiting cell proliferative disorders
SUGEN INC153 citations98
US5773459AJun 30, 1998
Urea- and thiourea-type compounds
SUGEN INC117 citations98
US5763198AJun 9, 1998
Screening assays for compounds
SUGEN INC155 citations98
US5700823ADec 23, 1997
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC122 citations98
US5763441AJun 9, 1998
Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
SUGEN INC111 citations97
US6696448B2Feb 24, 2004
3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
SUGEN INC65 citations96
US6683082B2Jan 27, 2004
Bicyclic protein kinase inhibitors
SUGEN INC60 citations96
US6677368B2Jan 13, 2004
4-aryl substituted indolinones
SUGEN INC72 citations96
US6653308B2Nov 25, 2003
3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
SUGEN INC75 citations96
US6610688B2Aug 26, 2003
4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
SUGEN INC74 citations96
US6486185B1Nov 26, 2002
3-heteroarylidene-2-indolinone protein kinase inhibitors
SUGEN INC64 citations96
US6326469B1Dec 4, 2001
Megakaryocytic protein tyrosine kinases
SUGEN INC184 citations96
US6316635B1Nov 13, 2001
2-indolinone derivatives as modulators of protein kinase activity
SUGEN INC87 citations96
US6239161B1May 29, 2001
Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
SUGEN INC54 citations96
US6225346B1May 1, 2001
Tyrphostin like compounds
SUGEN INC61 citations96
US6143765ANov 7, 2000
Pharmaceutical compositions and methods for modulating signal transduction
SUGEN INC44 citations96
US6103728AAug 15, 2000
Quinazolines
SUGEN INC58 citations96
US5990141ANov 23, 1999
Treatment of platelet derived growth factor related disorders such as cancers
SUGEN INC189 citations96
US5935993AAug 10, 1999
Tyrphostin like compounds
SUGEN INC72 citations96
US5891917AApr 6, 1999
Certain acrylonitrile-sulfonamide derivatives
SUGEN INC75 citations96
US5763470AJun 9, 1998
Benzopyran compounds and methods for their use
SUGEN INC57 citations96
US7230098B2Jun 12, 2007
Aminoheteroaryl compounds as protein kinase inhibitors
SUGEN INC73 citations95
US7125905B2Oct 24, 2006
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC59 citations95
US6777417B2Aug 17, 2004
3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors
SUGEN INC56 citations95
US6204267B1Mar 20, 2001
Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds
SUGEN INC61 citations95
US5602171AFeb 11, 1997
Methods of inhibiting phosphatase activity and treatment of disorders associated therewith using naphthopyrones and derivatives thereof
SUGEN INC54 citations95
US6716575B2Apr 6, 2004
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
SUGEN INC43 citations94
US6207401B1Mar 27, 2001
Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
SUGEN INC81 citations94
US5962312AOct 5, 1999
Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
SUGEN INC65 citations94
US7119090B2Oct 10, 2006
Pyrrole substituted 2-indolinone protein kinase inhibitors
SUGEN INC18 citations93
US6849641B1Feb 1, 2005
Azaindole tyrosine kinase inhibitors
SUGEN INC38 citations93
US6841579B1Jan 11, 2005
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
SUGEN INC125 citations93
US6514981B1Feb 4, 2003
Methods of modulating tyrosine protein kinase function with indolinone compounds
SUGEN INC30 citations93
US6329375B1Dec 11, 2001
Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
SUGEN INC27 citations93
Showing the top 50 of 158 patents by PatentIndex Score.